Review of Evidence Supporting 2022 US Food and Drug Administration Drug Approvals

This cross-sectional study examines the design and funding of studies, nd evidence available on ClinicalTrials.gov for drugs approved in 2022.

Detalles Bibliográficos
Autores principales: Kaplan, Robert M., Koong, Amanda J., Irvin, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410475/
https://www.ncbi.nlm.nih.gov/pubmed/37552481
http://dx.doi.org/10.1001/jamanetworkopen.2023.27650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410475/
https://www.ncbi.nlm.nih.gov/pubmed/37552481
http://dx.doi.org/10.1001/jamanetworkopen.2023.27650

Ejemplares similares